Evidence map›Paper›PMID 34059692›Full record

Trial reportScientific reports2021

Therapeutic effects and prognostic factors of

Rui Wang, Jinhu Zhu, Shu Yang, Xiaoqin Chen, Cairu Gu, Tong Liang, Ling Li, Dan Liu, Yanqing Cao

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Radiation oncology (London, England) · 2024
    Article
  3. Review
  4. Article
  5. Review
  6. Chinese Expert Consensus on IodineFrontiers in oncology · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rui WangDepartment of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, Guangdong, China.
Jinhu ZhuDepartment of Gynecology, GuangZhou Red Cross Hospital, Jinan University, Guangzhou, 510220, Guangdong, China. zhujinhu421@163.com.
Shu YangDepartment of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, Guangdong, China.
Xiaoqin ChenDepartment of Gynecology, GuangZhou Red Cross Hospital, Jinan University, Guangzhou, 510220, Guangdong, China.
Cairu GuDepartment of Gynecology, GuangZhou Red Cross Hospital, Jinan University, Guangzhou, 510220, Guangdong, China.
Tong LiangDepartment of Gynecology, GuangZhou Red Cross Hospital, Jinan University, Guangzhou, 510220, Guangdong, China.
Ling LiDepartment of Gynecology, GuangZhou Red Cross Hospital, Jinan University, Guangzhou, 510220, Guangdong, China.
Dan LiuDepartment of Gynecology, GuangZhou Red Cross Hospital, Jinan University, Guangzhou, 510220, Guangdong, China.
Yanqing CaoDepartment of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, Guangdong, China.
Jinan University · CNFirst Affiliated Hospital of Guangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the efficacy of

Indexed as

AdultAgedBrachytherapyCombined Modality TherapyFemaleHumansIodine RadioisotopesMiddle AgedNeoplasm Recurrence, LocalPelvisPrognosisProspective StudiesSurvival RateTreatment OutcomeUterine Cervical NeoplasmsIodine-125Iodine Radioisotopes

Identifiers

PMID34059692
PMCPMC8166881
OpenAlexW3165232598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.